WhatsApp Image 2025-04-16 at 07.05.43_602af11f
  • Odisha
    • Odia E-News
  • National
  • International
  • Administration
  • Business
  • Sports
  • More
    • Entertainment
    • Technology
    • Lifestyle
    • Health
    • Editorial
    • Interviews
    • Podcast
    • Event Times
    • Top 20 most Inspirational Awards of Odisha 2021
    • State Business Leadership Awards 2022
    • Top 20 Most Inspirational Personalities Of Odisha Awards 2022
    • 50 Most Enterprising Individuals Beyond Business
    • 50 Most Valuable Brands & Start-ups of Odisha 2023
    • State Business Leadership Awards 2024
    • Interview Times Presents – The PAN INDIA Start-up Saga
    • Top 20 Most Inspirational Personalities of Odisha Awards 2024
  • E-Magazine
    • January 2023 E-Magazine
    • October E-Magazine-2021
    • June E-Magazine-2021
    • March e-Magazine 2021
    • New Year Special Edition E-Magazine – 2021
    • November E-Magazine -2020
    • October E Magazine-2020
    • July E-Magazine-2020
WhatsApp Image 2025-04-16 at 07.05.43_602af11f
Search results for

"Covid antibody"

FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

Amid Fight Against Covid-19, ICMR Warns India Of ‘Cat Que Virus’

by September 29, 2020
by September 29, 2020 0 comment

Another Chinese Virus is known as “Cat Que virus” has been reported in China and Vietnam. According to researchers at the Indian Council of Medical research’s National Institute of Virology…

Read more
FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

With Covid-19, 86,000 Cases in 24 hours India Crossed 58 Lakh Cases

by September 25, 2020
by September 25, 2020 0 comment

With more than 86,000 cases in 24 hours, the Covid-19 count in India past 5.8 million on Friday. The deaths till likewise 92,290 with in excess of 1,000 passings during…

Read more
FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

India crossed 48 Lakh Mark With 92,071 New Cases In Covid-19

by September 14, 2020
by September 14, 2020 0 comment

The Covid-19 count in India crossed the 48 lakh-mark with 92,071 new cases recorded over the recent 24 hours. 1,136 deaths were accounted for on Sunday, causing significant damage to…

Read more
FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

Oxford Covid-19 vaccine trial begins

by interview2019 July 21, 2020
by interview2019 July 21, 2020 0 comment

At the University of Oxford, the trial for the vaccine to fight the deadly virus has begun. The vaccine formulated is safe and induces resistant reaction. The introductory outcomes published…

Read more
FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

Russian Vaccine, Density For World

by August 12, 2020
by August 12, 2020 0 comment

Russia has become the first nation on the planet to approve an immunization for the coronavirus, named Sputnik V, President Vladimir V. Putin reported on Tuesday, however worldwide specialists state…

Read more
FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

Sputnik Light vaccine gets nod for emergency use in India

by Dikhyaa Mohanty February 7, 2022
by Dikhyaa Mohanty February 7, 2022 0 comment

Apex drug regulator, the Drug Controller General on Sunday granted emergency use approval to single-dose Sputnik Light Covid-19 vaccine in India. As per the vaccine developer RDIF, the interim data…

Read more
FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

Antibodies Starts Declining After 2 Months Of Vaccination: RMRC-Bhubaneswar Study

by Dikhyaa Mohanty September 15, 2021
by Dikhyaa Mohanty September 15, 2021 0 comment

COVID antibodies start declining after two months in recipients of Covaxin and after three months in those vaccinated with Covishield as reported in a recent study led by ICMR-Regional Medical…

Read more
FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

20% Of Fully Vaccinated People In Odisha Fail To Develop Antibodies

by Dikhyaa Mohanty September 13, 2021
by Dikhyaa Mohanty September 13, 2021 0 comment

The Bhubaneswar-based Institute of Life Science (ILS) informed that about 20 per cent of the fully vaccinated people in Odisha have failed to develop antibodies against SARS-CoV2, and they may…

Read more
FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

Covishield, Covaxin Combination Brings Better Immunogenicity: ICMR

by Dikhyaa Mohanty August 9, 2021
by Dikhyaa Mohanty August 9, 2021 0 comment

As per a study by ICMR involving 98 people, 18 of whom had inadvertently received Covishield as first dose and Covaxin as the second in Uttar Pradesh showed that combining…

Read more
FacebookTwitterPinterestLinkedinWhatsappTelegramEmail

Pfizer To Seek US Authorisation For 3rd Vaccine Dose

by Dikhyaa Mohanty July 9, 2021
by Dikhyaa Mohanty July 9, 2021 0 comment

Pfizer will seek US authorisation for a third dose of its COVID-19 vaccine, and that another shot within 12 months could dramatically boost immunity and maybe help ward off the…

Read more
  • 1
  • 2
  • 3

Account Name: The Interview times
Branch: VSS Nagar, Bhubaneswar
Type of Account : Current
Account Number : 32649839112
IFSC Code : SBIN0007376

Subscribe to our Newsletter

The Interview Times—India’s first interview-based magazine, established in 2010 in Bhubaneswar, Odisha—has redefined the power of storytelling through conversations that matter. While its inspiring features and interviews have made it a household name across the state, what truly sets it apart is its visionary Conclaves and dialogues. These thought-leadership platforms bring together changemakers, trailblazers, and voices of impact to spark meaningful discourse on issues that shape our society. Bold, far-sighted, and rooted in relevance, these signature events are the hallmark of The Interview Times’ commitment to innovation in journalism—turning ideas into movements and stories into legacies.

VISIT US

POPULAR POSTS

  • Engineering the Future: Mr. Prakash A. Sulakhe
  • A Life Devoted to Academic Integrity, Innovation and Leadership
  • President Joe Biden Diagnosed with Prostate Cancer
  • BCCI to Boycott Asia Cup, Cites Inability to Play Under Pakistan-Led ACC

CONTACT US

  • timesinterview@gmail.com
  • +91-7978163782
  • +91-7735882900

FOLLOW US

Facebook Twitter Linkedin Instagram
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Our Team
Menu
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Our Team

Interview Times All rights reserved. Designed by Inter Softech

  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Our Team